Funding

Violet Therapeutics

United States · Biotech · Healthtech

Develops first-in-class small molecule therapies for neurodegenerative disease via glial cell signaling platform

Visit violettx.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Seed+$4.8MDementia Discovery Fund — Role not disclosedLifespan Vision Ventures — Role not disclosedMass General Brigham Ventures — Role not disclosedOno Venture Investment — Role not disclosedUTEC — Role not disclosed

Investors

Dementia Discovery FundSeed+Lifespan Vision VenturesSeed+Mass General Brigham VenturesSeed+Ono Venture InvestmentSeed+UTECSeed+

Coverage

May 18, 2026Violet Therapeutics · Seed+

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcesviolettx.com ↗